CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,467,021 | +25.0% | 861,333 | +2.1% | 0.01% | +40.0% |
| Q2 2023 | $18,772,258 | -2.6% | 843,697 | -5.2% | 0.01% | -16.7% |
| Q1 2023 | $19,276,599 | +6.6% | 889,963 | -0.0% | 0.01% | 0.0% |
| Q4 2022 | $18,077,444 | -14.3% | 890,076 | +8.2% | 0.01% | -25.0% |
| Q3 2022 | $21,093,000 | +8.8% | 822,657 | +0.9% | 0.01% | +14.3% |
| Q2 2022 | $19,386,000 | +9.6% | 815,192 | +3.8% | 0.01% | +40.0% |
| Q1 2022 | $17,694,000 | +31.5% | 785,716 | +15.6% | 0.01% | +25.0% |
| Q4 2021 | $13,460,000 | -10.6% | 679,765 | -11.2% | 0.00% | -20.0% |
| Q3 2021 | $15,064,000 | -10.6% | 765,437 | -0.0% | 0.01% | -16.7% |
| Q2 2021 | $16,842,000 | -10.4% | 765,542 | -3.1% | 0.01% | -14.3% |
| Q1 2021 | $18,804,000 | -5.9% | 790,409 | +3.5% | 0.01% | -12.5% |
| Q4 2020 | $19,986,000 | +53.1% | 763,955 | +1.9% | 0.01% | +33.3% |
| Q3 2020 | $13,050,000 | +1.3% | 749,782 | -2.1% | 0.01% | 0.0% |
| Q2 2020 | $12,882,000 | +56.7% | 765,858 | +10.8% | 0.01% | +20.0% |
| Q1 2020 | $8,221,000 | -1.1% | 691,380 | +0.6% | 0.01% | +25.0% |
| Q4 2019 | $8,313,000 | -2.1% | 686,972 | +14.4% | 0.00% | -20.0% |
| Q3 2019 | $8,487,000 | +28.5% | 600,355 | +1.4% | 0.01% | +25.0% |
| Q2 2019 | $6,605,000 | -3.3% | 592,299 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $6,828,000 | -9.1% | 581,519 | +3.4% | 0.00% | -33.3% |
| Q4 2018 | $7,512,000 | -4.7% | 562,269 | +0.0% | 0.01% | +20.0% |
| Q3 2018 | $7,883,000 | -0.1% | 562,213 | +12.0% | 0.01% | -16.7% |
| Q2 2018 | $7,891,000 | -2.2% | 501,937 | +2.3% | 0.01% | 0.0% |
| Q1 2018 | $8,072,000 | -7.1% | 490,663 | +2.0% | 0.01% | -14.3% |
| Q4 2017 | $8,686,000 | +8.7% | 480,924 | +16.1% | 0.01% | 0.0% |
| Q3 2017 | $7,994,000 | +82.8% | 414,175 | +11.8% | 0.01% | +75.0% |
| Q2 2017 | $4,373,000 | +17.3% | 370,573 | +9.0% | 0.00% | 0.0% |
| Q1 2017 | $3,727,000 | +60.2% | 339,982 | +6.1% | 0.00% | +33.3% |
| Q4 2016 | $2,327,000 | +28.1% | 320,455 | +14.7% | 0.00% | +50.0% |
| Q3 2016 | $1,817,000 | +184.4% | 279,401 | +139.0% | 0.00% | +100.0% |
| Q2 2016 | $639,000 | +57.8% | 116,906 | +35.1% | 0.00% | 0.0% |
| Q1 2016 | $405,000 | -6.0% | 86,506 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $431,000 | +32.2% | 86,506 | 0.0% | 0.00% | – |
| Q3 2015 | $326,000 | -37.3% | 86,506 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $520,000 | +35.4% | 86,506 | +26.5% | 0.00% | 0.0% |
| Q1 2015 | $384,000 | +86.4% | 68,400 | 0.0% | 0.00% | – |
| Q4 2014 | $206,000 | +12.0% | 68,400 | 0.0% | 0.00% | – |
| Q3 2014 | $184,000 | -4.2% | 68,400 | 0.0% | 0.00% | – |
| Q2 2014 | $192,000 | -35.8% | 68,400 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $299,000 | +35.3% | 68,400 | 0.0% | 0.00% | – |
| Q4 2013 | $221,000 | +99.1% | 68,400 | 0.0% | 0.00% | – |
| Q3 2013 | $111,000 | -9.0% | 68,400 | 0.0% | 0.00% | – |
| Q2 2013 | $122,000 | – | 68,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |